Variant report
Variant | nsv972036 |
---|---|
Chromosome Location | chr11:59845745-59853677 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:58)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr11:59846322-59846529 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr11:59853455-59853752 | K562 | blood: | n/a | n/a |
3 | BHLHE40 | chr11:59853433-59853683 | K562 | blood: | n/a | n/a |
4 | CBX3 | chr11:59845690-59846028 | K562 | blood: | n/a | n/a |
5 | CBX3 | chr11:59847993-59848492 | K562 | blood: | n/a | n/a |
6 | CCNT2 | chr11:59853478-59853769 | K562 | blood: | n/a | chr11:59853577-59853597 |
7 | CEBPB | chr11:59853381-59853929 | K562 | blood: | n/a | n/a |
8 | CEBPB | chr11:59852064-59852355 | HepG2 | liver: | n/a | n/a |
9 | CEBPB | chr11:59852045-59852314 | K562 | blood: | n/a | n/a |
10 | CEBPB | chr11:59849880-59850038 | K562 | blood: | n/a | n/a |
11 | CEBPB | chr11:59853497-59853883 | K562 | blood: | n/a | n/a |
12 | CEBPB | chr11:59853496-59853741 | K562 | blood: | n/a | n/a |
13 | CEBPD | chr11:59853327-59853826 | K562 | blood: | n/a | n/a |
14 | CEBPD | chr11:59853390-59853958 | K562 | blood: | n/a | n/a |
15 | CTCF | chr11:59847886-59847936 | GM20000 | blood: | n/a | n/a |
16 | EP300 | chr11:59853386-59853849 | K562 | blood: | n/a | n/a |
17 | FOXA1 | chr11:59852058-59852716 | T-47D | breast: | n/a | n/a |
18 | FOXA1 | chr11:59852295-59852634 | T-47D | breast: | n/a | n/a |
19 | GATA1 | chr11:59853307-59854012 | K562 | blood: | n/a | chr11:59853580-59853597 |
20 | GATA2 | chr11:59853360-59853823 | K562 | blood: | n/a | chr11:59853580-59853597 |
21 | GATA2 | chr11:59846177-59846586 | K562 | blood: | n/a | n/a |
22 | GATA3 | chr11:59852069-59852676 | T-47D | breast: | n/a | n/a |
23 | GATA3 | chr11:59852014-59852936 | T-47D | breast: | n/a | n/a |
24 | IRF1 | chr11:59853535-59853836 | K562 | blood: | n/a | n/a |
25 | IRF1 | chr11:59846302-59846542 | K562 | blood: | n/a | n/a |
26 | IRF1 | chr11:59853314-59853813 | K562 | blood: | n/a | n/a |
27 | JUN | chr11:59853492-59853782 | K562 | blood: | n/a | n/a |
28 | JUND | chr11:59853441-59853649 | K562 | blood: | n/a | n/a |
29 | KAP1 | chr11:59846561-59846729 | K562 | blood: | n/a | n/a |
30 | MAFF | chr11:59853539-59853769 | K562 | blood: | n/a | n/a |
31 | MAFK | chr11:59850981-59851071 | HepG2 | liver: | n/a | n/a |
32 | MAX | chr11:59853379-59853693 | K562 | blood: | n/a | n/a |
33 | MAZ | chr11:59853516-59853711 | K562 | blood: | n/a | n/a |
34 | MYC | chr11:59853461-59853660 | K562 | blood: | n/a | n/a |
35 | MYC | chr11:59853340-59853828 | K562 | blood: | n/a | n/a |
36 | NFYA | chr11:59853541-59853741 | K562 | blood: | n/a | n/a |
37 | NR2F2 | chr11:59853434-59853782 | K562 | blood: | n/a | n/a |
38 | PML | chr11:59853403-59853852 | K562 | blood: | n/a | n/a |
39 | POLR2A | chr11:59849325-59849342 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | POLR2A | chr11:59853543-59853609 | K562 | blood: | n/a | n/a |
41 | RCOR1 | chr11:59853423-59853753 | K562 | blood: | n/a | n/a |
42 | SPI1 | chr11:59853412-59853599 | HL-60 | blood: | n/a | chr11:59853487-59853494 chr11:59853486-59853495 |
43 | SPI1 | chr11:59853394-59853609 | K562 | blood: | n/a | chr11:59853487-59853494 chr11:59853486-59853495 |
44 | SPI1 | chr11:59853291-59853721 | HL-60 | blood: | n/a | chr11:59853487-59853494 chr11:59853486-59853495 |
45 | STAT3 | chr11:59847185-59847210 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | STAT5A | chr11:59853406-59853869 | K562 | blood: | n/a | chr11:59853755-59853767 |
47 | TAL1 | chr11:59846230-59846593 | K562 | blood: | n/a | n/a |
48 | TAL1 | chr11:59853401-59853895 | K562 | blood: | n/a | chr11:59853578-59853586 chr11:59853579-59853597 |
49 | TAL1 | chr11:59852127-59852320 | K562 | blood: | n/a | n/a |
50 | TBL1XR1 | chr11:59853563-59853740 | K562 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:59847145..59850103-chr11:59877853..59879913,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MS4A2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138153992 | chr11:59845800-59845801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs568691226 | chr11:59845801-59845802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149631635 | chr11:59845817-59845818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190200216 | chr11:59845821-59845822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568955247 | chr11:59845825-59845826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575690990 | chr11:59845828-59845829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543695 | chr11:59845829-59845830 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs144403490 | chr11:59845876-59845877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550889767 | chr11:59845888-59845889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148805023 | chr11:59845914-59845915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540160368 | chr11:59845919-59845920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs115067373 | chr11:59845935-59845936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529062574 | chr11:59845952-59845953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181652905 | chr11:59845955-59845956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75229144 | chr11:59845959-59845960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184622992 | chr11:59846004-59846005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7102260 | chr11:59846035-59846036 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs114855406 | chr11:59846059-59846060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554081808 | chr11:59846072-59846073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560403289 | chr11:59846077-59846078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527250127 | chr11:59846096-59846097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547331573 | chr11:59846117-59846118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189222479 | chr11:59846158-59846159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79832628 | chr11:59846192-59846193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12362446 | chr11:59846233-59846234 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs569289752 | chr11:59846235-59846236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114211879 | chr11:59846238-59846239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181923381 | chr11:59846274-59846275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557804426 | chr11:59846285-59846286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572918522 | chr11:59846308-59846309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs78247616 | chr11:59846325-59846326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185930136 | chr11:59846333-59846334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572232822 | chr11:59846347-59846348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372796287 | chr11:59846350-59846351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113072504 | chr11:59846352-59846353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74899468 | chr11:59846396-59846397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190800325 | chr11:59846401-59846402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs367997948 | chr11:59846415-59846416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181370195 | chr11:59846466-59846467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139865518 | chr11:59846484-59846485 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549680 | chr11:59846494-59846495 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs186517082 | chr11:59846498-59846499 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549651 | chr11:59846504-59846505 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs554429054 | chr11:59846508-59846509 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548997017 | chr11:59846573-59846574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190538898 | chr11:59846575-59846576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs574575634 | chr11:59846608-59846609 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182923556 | chr11:59846611-59846612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540502945 | chr11:59846639-59846640 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs529576272 | chr11:59846647-59846648 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495309 | CNVD |
Autism | 20808228 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Chordoma | 21602918 | CNVD |
Melanoma | 18172304 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:59844000-59847600 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr11:59844800-59846400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
3 | chr11:59845400-59846000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
4 | chr11:59845600-59846600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr11:59845800-59846600 | Enhancers | K562 | blood |
6 | chr11:59846400-59847400 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
7 | chr11:59846600-59847400 | Weak transcription | K562 | blood |
8 | chr11:59847400-59847600 | Enhancers | K562 | blood |
9 | chr11:59847400-59847600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr11:59847600-59852000 | Weak transcription | K562 | blood |
11 | chr11:59851800-59852800 | Enhancers | Fetal Brain Male | brain |
12 | chr11:59852000-59853400 | Enhancers | K562 | blood |
13 | chr11:59852200-59852800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr11:59852600-59853000 | Enhancers | Brain Germinal Matrix | brain |
15 | chr11:59853200-59853600 | Enhancers | Brain Germinal Matrix | brain |
16 | chr11:59853200-59853800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr11:59853400-59854000 | Flanking Active TSS | K562 | blood |